BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalogeropoulos AP, Georgiopoulou VV, Butler J. Clinical adoption of prognostic biomarkers: the case for heart failure. Prog Cardiovasc Dis 2012;55:3-13. [PMID: 22824105 DOI: 10.1016/j.pcad.2012.05.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Kalogeropoulos AP, Georgiopoulou VV, Borlaug BA, Gheorghiade M, Butler J. Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research. Circ Heart Fail 2013;6:584-93. [PMID: 23694772 DOI: 10.1161/CIRCHEARTFAILURE.112.000096] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
2 Behnes M, Bertsch T, Weiss C, Ahmad-nejad P, Akin I, Fastner C, El-battrawy I, Lang S, Neumaier M, Borggrefe M, Hoffmann U. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients. International Journal of Cardiology 2016;203:398-406. [DOI: 10.1016/j.ijcard.2015.10.127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
3 Georgiopoulou VV, Tang WW, Giamouzis G, Li S, Deka A, Dunbar SB, Butler J, Kalogeropoulos AP. Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium. International Journal of Cardiology 2016;218:136-43. [DOI: 10.1016/j.ijcard.2016.05.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Franco J, Formiga F, Chivite D, Manzano L, Carrera M, Arévalo-lorido JC, Epelde F, Cerqueiro JM, Serrado A, Pérez-barquero MM. New onset heart failure — Clinical characteristics and short-term mortality. A RICA (Spanish registry of acute heart failure) study. European Journal of Internal Medicine 2015;26:357-62. [DOI: 10.1016/j.ejim.2015.04.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 5.1] [Reference Citation Analysis]
5 Coburn E, Frishman W. Comprehensive review of the prognostic value of galectin-3 in heart failure. Cardiol Rev 2014;22:171-5. [PMID: 24407048 DOI: 10.1097/CRD.0000000000000013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
6 Kalogeropoulos AP, Tang WHW, Hsu A, Felker GM, Hernandez AF, Troughton RW, Voors AA, Anker SD, Metra M, Mcmurray JJ, Massie BM, Ezekowitz JA, Califf RM, O’connor CM, Starling RC, Butler J. High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial. Journal of Cardiac Failure 2014;20:319-26. [DOI: 10.1016/j.cardfail.2014.02.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
7 Xiao N, Zhang J, Chen C, Wan Y, Wang N, Yang J. miR-129-5p improves cardiac function in rats with chronic heart failure through targeting HMGB1. Mamm Genome 2019;30:276-88. [PMID: 31646380 DOI: 10.1007/s00335-019-09817-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
8 Satyamurthy I, Dalal JJ, Sawhney JP, Mohan JC, Chogle SA, Desai N, Sathe SP, Maisel AS. The Indian Consensus Document on cardiac biomarker. Indian Heart J 2014;66:73-82. [PMID: 24581100 DOI: 10.1016/j.ihj.2013.12.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Kitagawa Y, Kawamura I, Suzuki K, Okada H, Ishihara T, Tomita H, Suzuki K, Takada C, Sampei S, Kano S, Kondo K, Asano H, Wakayama Y, Kamidani R, Kawasaki Y, Fukuda H, Nishio A, Miyake T, Fukuta T, Yasuda R, Oiwa H, Kakino Y, Miyazaki N, Watanabe T, Yoshida T, Doi T, Suzuki A, Yoshida S, Matsuo H, Ogura S. Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival. PLoS One 2021;16:e0260350. [PMID: 34879094 DOI: 10.1371/journal.pone.0260350] [Reference Citation Analysis]
10 Szczurek W, Szyguła-Jurkiewicz B. Oxidative stress and inflammatory markers - the future of heart failure diagnostics? Kardiochir Torakochirurgia Pol 2015;12:145-9. [PMID: 26336497 DOI: 10.5114/kitp.2015.52856] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kalogeropoulos AP, Georgiopoulou VV, Butler J. Biomarkers in Acute Heart Failure: From Risk Markers to Therapeutic Targets. Congest Heart Fail 2013;19:51-2. [DOI: 10.1111/chf.12019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, Matsui T, Matsuo S, Travin MI, Jacobson AF. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 2014;41:1673-82. [PMID: 24663289 DOI: 10.1007/s00259-014-2759-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
13 Janković R, Marković D, Savić N, Dinić V. Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers. Biomed Res Int 2015;2015:187384. [PMID: 26504786 DOI: 10.1155/2015/187384] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
14 Stone JR. Novel prognostic tissue markers in congestive heart failure. Cardiovascular Pathology 2015;24:65-70. [DOI: 10.1016/j.carpath.2014.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
15 Hoffmann U, Espeter F, Weiß C, Ahmad-Nejad P, Lang S, Brueckmann M, Akin I, Neumaier M, Borggrefe M, Behnes M. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. BMC Cardiovasc Disord 2015;15:50. [PMID: 26072112 DOI: 10.1186/s12872-015-0026-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
16 Aramburu-Bodas Ó, García-Casado B, Salamanca-Bautista P, Guisado-Espartero ME, Arias-Jiménez JL, Barco-Sánchez A, Santamaría-González JC, Formiga F, Montero-Pérez-Barquero M, Manzano L. Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction. J Cardiovasc Med (Hagerstown) 2015;16:438-43. [PMID: 25469731 DOI: 10.2459/JCM.0000000000000229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]